官方服务：
资源简介：
Investigating the impact of Bif.BEVs on anti-PD-1 therapy in lung cancer.
应用场景：
创建时间：
2025-03-03
相关数据集
CRISPR screening reveals targets to reprogram long-lived effector CD8+ T cells for cancer therapy [scRNA-seq]
CD8+ T cells can be reprogrammed for better persistence and robust effector function in TME. By performing an in vivo pooled CRISPR-Cas9 mutagenesis screening of metabolism-associated factors, we iden
NIAID Data Ecosystem00
Data Sheet 1_A CD47 antibody with minimized erythrocyte and thrombocyte toxicities.docx
IntroductionBlockade of the CD47/SIRPa axis has emerged as a promising approach to enhance macrophage-mediated anti-tumor activities in cancer immunotherapy. However, the clinical application of early
NIAID Data Ecosystem00
DataSheet4_A systematic pan-cancer analysis reveals the clinical prognosis and immunotherapy value of C-X3-C motif ligand 1 (CX3CL1).ZIP
It is now widely known that C-X3-C motif ligand 1 (CX3CL1) plays an essential part in the process of regulating pro-inflammatory cells migration across a wide range of inflammatory disorders, includin
NIAID Data Ecosystem00
Co-cultures between hgp100-pulsed splenocytes with Pmel mouse CD8 T cells treated with human recombinant AOAH protein or vehicle (10% glycerol PBS)
Secreted proteins are central mediators of intercellular communications and can serve as therapeutic targets in diverse diseases. The ~1903 human genes encoding secreted proteins are difficult to stud
NIAID Data Ecosystem00
